Table 1 The clinical distribution characteristics of adverse events reported for alendronate
Characteristic | Alendronate (N, %) |
|---|---|
Number of patients experiencing adverse reactions | 31,446(100.0%) |
Gender | |
 Female | 25,475 (81.0%) |
 Male | 2637 (8.4%) |
 Missing | 3334 (10.6%) |
Age (year) | |
 < 18 | 66 (0.2%) |
 18–64.9 | 6213 (19.8%) |
 65–85 | 8994 (28.6%) |
 > 85 | 1009 (3.2%) |
 Missing | 15,164 (48.2%) |
Weight(kg) | |
 < 50 | 919 (2.9%) |
 50–100 | 8029 (25.5%) |
 > 100 | 295 (0.9%) |
 Missing | 22,203 (70.6%) |
Reporter’s type of occupation | |
 Consumer | 11,539 (36.7%) |
 Health Professional | 1392 (4.4%) |
 Lawyer | 2333 (7.4%) |
 Physician | 7949 (25.3%) |
 Other health-professional | 4660 (14.8%) |
 Pharmacist | 1231 (3.9%) |
 Registered Nurse | 5 (0.0%) |
 Missing | 2337 (7.4%) |